Memantine Hydrochloride NDC 61442-193

NDC codes

FDA NDC Directory

Product NDC (as listed)61442-193Labeler and product segments. Claims need a package NDC.

Product NDC at billing width61442-0193Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
61442-193-05	61442019305	500 TABLET, FILM COATED in 1 BOTTLE (61442-193-05)Marketed from Jun 22, 2025
61442-193-60	61442019360	60 TABLET, FILM COATED in 1 BOTTLE (61442-193-60)Marketed from Jun 22, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Memantine Hydrochloride
Generic name (nonproprietary): memantine hydrochloride
Active ingredients: Memantine hydrochloride — 10 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Carlsbad Technology, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212947
Marketing start: Jun 22, 2025
Listing expires: Dec 31, 2027
Other FDA classes: NMDA Receptor Antagonists (Mechanism)
Identifiers: Product ID 61442-193_3430551c-c9c0-c8ab-e063-6394a90adfbaSPL ID 3430551c-c9c0-c8ab-e063-6394a90adfbaSPL set ID 30b4d5c4-0a31-c385-e063-6394a90adbceRxCUI 996561, 996571UNII JY0WD0UA60UPC 0361442192051, 0361442193058
Pharmacologic class: N-methyl-D-aspartate Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N461442019305 followed by a unit qualifier and the quantity

Package 61442-0193-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 23, 2025.

Indications (excerpt from the label)

Memantine Hydrochloride Tablets are indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. Memantine Hydrochloride Tablets are an N-methyl-D-aspartate (NMDA) receptor antagonist indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 212947

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 212947
Product	Strength	Form · route	Labeler	Product NDC
Memantine Hydrochloride	Memantine hydrochloride 5 mg/1	Tablet, Film coatedOral	Carlsbad Technology, Inc.	61442-192